Vitrakvi 100 mg (Larotrectinib (Larotrectinib Sulfate) CAPSULE) 100 MG

VITRAKVI 100 MG capsules contain larotrectinib sulfate, a medication used for targeted therapy. This oral treatment is designed to address specific genetic alterations in cancer cells.

Strength

100 MG

Manufacturer / TM Owner

BAYER INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VITRAKVI 100 MG capsules are primarily used in the treatment of cancers that have a specific genetic alteration known as NTRK gene fusion. This medication is part of a class of drugs known as kinase inhibitors, which work by targeting the abnormal proteins produced by these genetic changes. Patients may wonder, 'What is VITRAKVI used for?' This drug is intended for conditions where the NTRK gene fusion is present, helping to slow or stop the growth of cancer cells.

Side Effects

Common effects of VITRAKVI 100 MG capsules may include fatigue, nausea, and dizziness. Some patients might experience changes in taste or vision. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Precautions & Warnings

VITRAKVI 100 MG capsules should be handled with care. Store the medication at room temperature, away from moisture and heat. Always follow the instructions provided by your healthcare professional. Inform your doctor about any other medications you are taking to avoid potential interactions.

Avoid Interactions

VITRAKVI 100 MG capsules may interact with certain medications, including those that are metabolized by the liver's CYP3A enzyme. It's important to discuss all current medications with your healthcare provider to ensure safe and effective use of this drug.

Frequently Asked Questions

VITRAKVI is used to treat cancers with NTRK gene fusions, targeting specific genetic alterations in cancer cells.

Store VITRAKVI capsules at room temperature, away from moisture and heat.

Common side effects may include fatigue, nausea, dizziness, changes in taste, and vision changes.

Yes, VITRAKVI may interact with medications metabolized by the liver's CYP3A enzyme.

VITRAKVI is available in 100 MG capsules, but other strengths may be available depending on the manufacturer.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.